Literature DB >> 21541783

Diabetes, treatments for diabetes and their effect on cancer incidence and mortality: attempts to disentangle the web of associations.

S H Wild1.   

Abstract

The association between type 2 diabetes and some types of cancer is well established and the complexity of this association is receiving increasing recognition. Many factors influence the risk of both diabetes and cancer including age, sex, ethnicity, socioeconomic status, obesity/insulin resistance, diet (including alcohol intake), physical activity levels and smoking history. The presence of diabetes may influence the uptake of cancer screening. Using an experimental approach to investigate the effect of better control of diabetes is helpful in assessing whether hyperglycaemia has a causal relationship with cancer. Diabetes treatments may influence the risk of cancer independently of their effect on glycaemia and complicate investigation of the association between diabetes and cancer. This article discusses the complexity involved in attempting to clarify the factors that contribute to the associations between diabetes, hyperglycaemia, diabetes treatment and cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21541783     DOI: 10.1007/s00125-011-2169-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  19 in total

1.  THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?

Authors:  A B HILL
Journal:  Proc R Soc Med       Date:  1965-05

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

4.  Does insulin therapy promote, reduce, or have a neutral effect on cancers?

Authors:  Hertzel C Gerstein
Journal:  JAMA       Date:  2010-02-03       Impact factor: 56.272

5.  Intensive glucose control and risk of cancer in patients with type 2 diabetes.

Authors:  G Stefansdottir; S Zoungas; J Chalmers; A P Kengne; M J Knol; H G M Leufkens; A Patel; M Woodward; D E Grobbee; M L De Bruin
Journal:  Diabetologia       Date:  2011-04-21       Impact factor: 10.122

6.  Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials.

Authors:  J A Johnson; S L Bowker
Journal:  Diabetologia       Date:  2010-10-20       Impact factor: 10.122

Review 7.  Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

Authors:  Andrea Decensi; Matteo Puntoni; Pamela Goodwin; Massimiliano Cazzaniga; Alessandra Gennari; Bernardo Bonanni; Sara Gandini
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-12

8.  Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden.

Authors:  Kazem Zendehdel; Olof Nyrén; Claes-Göran Ostenson; Hans-Olov Adami; Anders Ekbom; Weimin Ye
Journal:  J Natl Cancer Inst       Date:  2003-12-03       Impact factor: 13.506

9.  Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.

Authors:  Xilin Yang; Gary T C Ko; Wing Yee So; Ronald C W Ma; Linda W L Yu; Alice P S Kong; Hailu Zhao; Chun-Chung Chow; Peter C Y Tong; Juliana C N Chan
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

10.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

View more
  9 in total

1.  Type II Diabetes, Obesity, and Breast Cancer Risk: The Multiethnic Cohort.

Authors:  Gertraud Maskarinec; Simone Jacobs; Song-Yi Park; Christopher A Haiman; Veronica W Setiawan; Lynne R Wilkens; Loïc Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-13       Impact factor: 4.254

2.  Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment.

Authors:  Kristina Ranc; Marit E Jørgensen; Søren Friis; Bendix Carstensen
Journal:  Diabetologia       Date:  2014-03-15       Impact factor: 10.122

3.  Trends in cancer mortality among people with vs without diabetes in the USA, 1988-2015.

Authors:  Jessica L Harding; Linda J Andes; Edward W Gregg; Yiling J Cheng; Hannah K Weir; Kai M Bullard; Nilka Ríos Burrows; Giuseppina Imperatore
Journal:  Diabetologia       Date:  2019-09-12       Impact factor: 10.122

4.  Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals.

Authors:  Bendix Carstensen; Stephanie H Read; Søren Friis; Reijo Sund; Ilmo Keskimäki; Ann-Marie Svensson; Rickard Ljung; Sarah H Wild; Joannes J Kerssens; Jessica L Harding; Dianna J Magliano; Soffia Gudbjörnsdottir
Journal:  Diabetologia       Date:  2016-02-29       Impact factor: 10.122

5.  Effects and Mechanisms of Metformin on the Proliferation of Esophageal Cancer Cells In Vitro and In Vivo.

Authors:  Jian-Cai Tang; Rui An; Yi-Qing Jiang; Jian Yang
Journal:  Cancer Res Treat       Date:  2016-11-11       Impact factor: 4.679

Review 6.  2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications.

Authors:  Nieves González; Isabel Prieto; Laura Del Puerto-Nevado; Sergio Portal-Nuñez; Juan Antonio Ardura; Marta Corton; Beatriz Fernández-Fernández; Oscar Aguilera; Carmen Gomez-Guerrero; Sebastián Mas; Juan Antonio Moreno; Marta Ruiz-Ortega; Ana Belen Sanz; Maria Dolores Sanchez-Niño; Federico Rojo; Fernando Vivanco; Pedro Esbrit; Carmen Ayuso; Gloria Alvarez-Llamas; Jesús Egido; Jesús García-Foncillas; Alberto Ortiz
Journal:  Oncotarget       Date:  2017-03-14

7.  Long Non-Coding RNA LINC01572 Promotes Hepatocellular Carcinoma Progression via Sponging miR-195-5p to Enhance PFKFB4-Mediated Glycolysis and PI3K/AKT Activation.

Authors:  Shihui Lai; Zhipeng Quan; Yuesong Hao; Jun Liu; Zhiqian Wang; Luo Dai; Hongliang Dai; Songqing He; Bo Tang
Journal:  Front Cell Dev Biol       Date:  2021-12-14

8.  Association of serum C-peptide concentrations with cancer mortality risk in pre-diabetes or undiagnosed diabetes.

Authors:  Chih-Neng Hsu; Chia-Hsuin Chang; Yu-Sheng Lin; Jou-Wei Lin; James L Caffrey
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

Review 9.  Metformin in obesity, cancer and aging: addressing controversies.

Authors:  Lev M Berstein
Journal:  Aging (Albany NY)       Date:  2012-05       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.